tm logo
DTX PHARMA
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 08 Jan 2024

Last Applicant/ Owned by

10655 Sorrento Valley Road, Suite 100

San Diego

CA

92121

Serial Number

97249797 filed on 02th Feb 2022

Registration Number

N/A

Correspondent Address

Maury M. Tepper, III

Tepper & Eyster, PLLC

3724 Benson Drive

Raleigh,NC 27609

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PHARMA"

DTX PHARMA

Pharmaceutical research and development of oligonucleotide compounds; scientific research and product development in the field of oligonucleotide compounds and drug discovery; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development; Pharmaceutical research and development of fatty acid-based drug delivery platforms for usRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development of oligonucleotide compounds; scientific research and product development in the field of oligonucleotide compounds and drug discovery; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in the treatment of genetic diseases; Pharmaceutical research and development of therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases

Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, oligonucleotide compounds; oligonucleotide compounds for the treatment of genetic diseases; oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases; therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases; fatty acid-based oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases

Mark Details


Serial Number

No 97249797

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08th Jan 2024SOU TEAS EXTENSION RECEIVED
08th Jan 2024SOU EXTENSION 1 FILED
08th Jan 2024SOU EXTENSION 1 GRANTED
12th Dec 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12th Dec 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12th Dec 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
12th Dec 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
18th Jul 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23rd May 2023PUBLISHED FOR OPPOSITION